Editorial - GPs must be free to make prescribing decisions

This week we reveal that GPs have been barred from prescribing certain NICE-approved drugs because PCTs believe them to be too costly. This is a clear example of how budget cuts and financial pressures are making it difficult for frontline medical staff to follow best practice. It also makes a mockery of the NHS's system for approving and recommending drugs.

NICE is not always popular, but this is because it makes difficult decisions about what can and cannot be afforded in a cash-limited NHS. It uses the latest evidence to set standards and recommend treatments based on efficacy, cost and safety. This should, in theory, end the postcode lottery and mean such decisions are not left to local managers.

However, time and again PCTs choose to ignore NICE and establish local policies, almost always because of cost. Such local policies often interfere with GPs' abilities to provide their patients with the best quality care. If something is recommended by NICE, it should be available to patients regardless of where they live.

GPs accept that they need to be aware of the costs of their actions. In particular, they understand the importance of prescribing cost-effectively. However, they should not be placed in a position where they are expected to put cost ahead of the best interests of the patient in front of them. They must be allowed to make decisions about prescribing - and any other treatment for that matter - based on the individual patient's needs.

If we are reaching a point where financial restrictions are hampering GPs from following best practice, the government needs to step in. Ministers have been quick to act in the past when PCTs blocked high-profile cancer drugs, and last week health secretary Andrew Lansley took steps to reduce waiting times that have been rising in the wake of budget constraints. We need a similar no-nonsense approach here.

It is right for the NHS to be mindful of the drugs bill, but the DoH must put an end to drugs 'blacklists' if they are not supported by clinical evidence and prevent patients accessing the medicines they need.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Under 40s to be offered alternative to AstraZeneca COVID-19 vaccine

Under 40s to be offered alternative to AstraZeneca COVID-19 vaccine

Patients aged 30-39 will be offered an alternative to the Oxford/AstraZeneca COVID-19...

GPs per patient down 10% in just five years, NHS data reveal

GPs per patient down 10% in just five years, NHS data reveal

The number of fully-qualified, full-time equivalent (FTE) GPs per patient in England...

Supportive model must replace harmful CQC inspections, BMA chair warns

Supportive model must replace harmful CQC inspections, BMA chair warns

CQC inspections that ‘divert time away from patient care’ and ‘instil fear’ among...

UK COVID-19 vaccination programme tracker

UK COVID-19 vaccination programme tracker

GPs across the UK are playing a leading role in the largest-ever NHS vaccination...

A 'tsunami' of work is drowning general practice: GPs speak out about a profession at its limit

A 'tsunami' of work is drowning general practice: GPs speak out about a profession at its limit

Rocketing workloads created by huge backlogs of cases and continuing COVID-19 disruption...

Slight increase in GP workforce during past year, but number of partners continues to fall

Slight increase in GP workforce during past year, but number of partners continues to fall

The GP workforce grew by 0.4% in the year to March 2021, but the number of GP partners...